| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Departments of Physiology and Obstetrics and Gynecology (J.S.R.), University of Adelaide, Adelaide, South Australia 5005, Australia
Address all correspondence and requests for reprints to: Dr. I. C. McMillen, Department of Physiology, Medical School Building, University of Adelaide, G.P.O. Box 498, North Terrace, Adelaide, South Australia 5005, Australia. E-mail: caroline.mcmillen{at}adelaide.edu.au
We have investigated the effects of fetal growth restriction, induced by restriction of placental growth and function (PR), on 11ß-hydroxysteroid dehydrogenase type 1 (11ßHSD-1) and 11ßHSD-2 messenger RNA (mRNA) expression in fetal tissues in the sheep, using Northern blot analysis. Fetal liver, kidney, and adrenals were collected from normally grown fetuses at 90 days (n = 6), 125 days (n = 6), and 141145 days (n = 7) and from PR fetuses at 141145 days (n = 6). Expression of 11ßHSD-1 mRNA in the fetal liver increased significantly between 125 days (7.4 ± 0.8) and 141145 days gestation (27 ± 5.3). There was also an approximately 2-fold increase in the ratio of 11ßHSD-1 mRNA/18S rRNA expression in the PR group (53.8 ± 7.9) compared with that in control animals at 141145 days gestation. There was a significant decrease in 11ßHSD-2 mRNA in fetal adrenals between 125 days (41.6 ± 2.4) and 141145 days (26.7 ± 1.1) gestation, but there was no effect of PR on the expression of adrenal 11ßHSD-2 mRNA. 11ßHSD-2 mRNA expression in the fetal kidney increased between 90 days (16.8 ± 1.7) and 141145 days gestation (31.7 ± 4.3), but there was no effect of PR on the levels of 11ßHSD-2 mRNA in the fetal kidney. In summary, 11ßHSD-2 mRNA is differentially regulated in the fetal adrenal and kidney in the sheep fetus during late gestation. There is also a specific increase in the expression of 11ßHSD-1 mRNA in the liver of growth-restricted fetuses in late gestation. This suggests that there is increased hepatic exposure to cortisol in the growth-restricted fetus, which may be important in the reprogramming of hepatic physiology that occurs after growth restriction in utero.
This article has been cited by other articles:
![]() |
S. M. MacLaughlin, S. K. Walker, D. O. Kleemann, J. P. Sibbons, D. N. Tosh, S. Gentili, C. L. Coulter, and I. C. McMillen Impact of Periconceptional Undernutrition on Adrenal Growth and Adrenal Insulin-Like Growth Factor and Steroidogenic Enzyme Expression in the Sheep Fetus during Early Pregnancy Endocrinology, April 1, 2007; 148(4): 1911 - 1920. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nammi, K. Dembele, and B. L. G. Nyomba Increased 11beta-hydroxysteroid dehydrogenase type-1 and hexose-6-phosphate dehydrogenase in liver and adipose tissue of rat offspring exposed to alcohol in utero Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2007; 292(3): R1101 - R1109. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. C. Mcmillen and J. S. Robinson Developmental Origins of the Metabolic Syndrome: Prediction, Plasticity, and Programming Physiol Rev, April 1, 2005; 85(2): 571 - 633. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.E. Warnes, I.C. McMillen, J.S. Robinson, and C.L. Coulter Differential Actions of Metyrapone on the Fetal Pituitary-Adrenal Axis in the Sheep Fetus in Late Gestation Biol Reprod, August 1, 2004; 71(2): 620 - 628. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Coulter, I. C. McMillen, I. M. Bird, and M. D. Salkeld Steroidogenic Acute Regulatory Protein Expression Is Decreased in the Adrenal Gland of the Growth-Restricted Sheep Fetus During Late Gestation Biol Reprod, August 1, 2002; 67(2): 584 - 590. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E Bertram and M. A Hanson Animal models and programming of the metabolic syndrome: Type 2 diabetes Br. Med. Bull., November 1, 2001; 60(1): 103 - 121. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bertram, A. R. Trowern, N. Copin, A. A. Jackson, and C. B. Whorwood The Maternal Diet during Pregnancy Programs Altered Expression of the Glucocorticoid Receptor and Type 2 11{beta}-Hydroxysteroid Dehydrogenase: Potential Molecular Mechanisms Underlying the Programming of Hypertension in Utero Endocrinology, July 1, 2001; 142(7): 2841 - 2853. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. B. Whorwood, K. M. Firth, H. Budge, and M. E. Symonds Maternal Undernutrition during Early to Midgestation Programs Tissue-Specific Alterations in the Expression of the Glucocorticoid Receptor, 11{beta}-Hydroxysteroid Dehydrogenase Isoforms, and Type 1 Angiotensin II Receptor in Neonatal Sheep Endocrinology, July 1, 2001; 142(7): 2854 - 2864. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |